Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquired_by |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:ceo |
gptkb:Christophe_Weber
|
| gptkbp:employees |
over 20,000
|
| gptkbp:founded |
gptkb:1986
|
| gptkbp:headquarters |
gptkb:Lexington,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Shire US Inc.
|
| gptkbp:operates_in |
gptkb:Europe
gptkb:Asia gptkb:North_America |
| gptkbp:products |
gptkb:Adderall
gptkb:Intuniv gptkb:Vyvanse Gaucher disease treatments |
| gptkbp:revenue |
$15 billion (2017)
|
| gptkbp:specializes_in |
rare diseases
|
| gptkbp:bfsParent |
gptkb:Shire_plc
|
| gptkbp:bfsLayer |
5
|